Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.80% | 25.83% | 31.52% | 30.92% | 32.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.80% | 25.83% | 31.52% | 30.92% | 32.93% |
| Cost of Revenue | 29.35% | 38.67% | 41.25% | 42.88% | 45.23% |
| Gross Profit | 21.08% | 22.74% | 29.22% | 28.12% | 30.03% |
| SG&A Expenses | 14.83% | 20.87% | 17.96% | 16.52% | 18.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.34% | 47.92% | 35.79% | 22.22% | 22.77% |
| Operating Income | -0.63% | -12.11% | 21.29% | 53.05% | 59.78% |
| Income Before Tax | 10.62% | -1.39% | 23.18% | 57.37% | 65.63% |
| Income Tax Expenses | 3.97% | 94.84% | 175.43% | 170.61% | 158.01% |
| Earnings from Continuing Operations | 12.91% | -18.66% | -42.57% | -27.32% | -28.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.91% | -18.66% | -42.57% | -27.32% | -28.99% |
| EBIT | -0.63% | -12.11% | 21.29% | 53.05% | 59.78% |
| EBITDA | -0.67% | -10.81% | 18.35% | 44.98% | 50.72% |
| EPS Basic | 18.12% | -14.96% | -41.23% | -26.52% | -29.35% |
| Normalized Basic EPS | 9.54% | -2.24% | 33.87% | 67.56% | 74.06% |
| EPS Diluted | 18.49% | -14.34% | -40.46% | -25.58% | -28.72% |
| Normalized Diluted EPS | 9.17% | -1.74% | 35.47% | 70.59% | 77.16% |
| Average Basic Shares Outstanding | -4.35% | -4.30% | -2.79% | -1.09% | 0.51% |
| Average Diluted Shares Outstanding | -4.16% | -4.98% | -4.13% | -2.90% | -1.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |